Research progress on anti-aging effects and mechanisms of the new ginsenoside Compound K
Zhiqin Fang,
No information about this author
Jingyin Zhang,
No information about this author
Jianwen Huang
No information about this author
et al.
Deleted Journal,
Journal Year:
2025,
Volume and Issue:
2(1), P. 100072 - 100072
Published: Jan. 31, 2025
Language: Английский
Potassium and Magnesium in American Ginseng Roots as Key Factors in Monitoring Soil Quality, Yield, and Quality: Screening, Prediction, and Validation
Jiaqi Qian,
No information about this author
Hai Sun,
No information about this author
Cai Shao
No information about this author
et al.
Horticulturae,
Journal Year:
2024,
Volume and Issue:
10(4), P. 344 - 344
Published: March 29, 2024
Understanding
the
key
roles
of
nutrient
elements
in
soil–plant
systems
are
essential
for
herbal
medicine
production
and
sustainable
development.
However,
ecological
relationships
between
soil
quality
elements,
yield,
saponins,
or
other
active
compounds
American
ginseng
remain
unclear.
In
this
study,
20
indicators,
10
root
9
yields
were
investigated.
The
minimum
dataset
was
constructed
by
principal
component
analysis,
factors
screened
correlation
analysis
PLS-PM
prediction
model
using
linear
fitting
tested
a
validation
test.
dataset,
based
on
comprised
five
indicators:
SOM,
TP,
AK,
AMg,
ACa.
Correlation
showed
that
K
Mg
relating
to
yield
when
AMg
0.21
g/kg
AK
0.30
g/kg,
organic
matter
27%,
total
phosphorus
1.19
soil,
content
roots
15.63
1.91
K/Mg
8.85
could
balance
quality.
predicting
validating
model,
DW,
ginsenoside,
Rb1,
Rb2,
Rc,
Rd
reliable.
This
study
provides
scientific
basis
regulation,
selecting
planting
sites,
assessing
quality,
evaluating
Language: Английский
Ginsenoside compound K alleviates d-galactose-induced mild cognitive impairment by modulating gut microbiota-mediated short-chain fatty acid metabolism
Food & Function,
Journal Year:
2024,
Volume and Issue:
15(18), P. 9037 - 9052
Published: Jan. 1, 2024
The
occurrence
and
progression
of
mild
cognitive
impairment
(MCI)
are
closely
related
to
dysbiosis
the
gut
microbiota.
Ginsenoside
compound
K
(CK),
a
bioactive
component
ginseng,
has
been
shown
alleviate
microbiota
neural
damage.
However,
mechanisms
by
which
CK
regulates
improve
MCI
remain
unexplored.
In
this
study,
an
mouse
model
induced
D-galactose
was
used,
16S
rRNA
gene
sequencing,
metabolomics,
transcriptomics,
integrative
multi-omics
analyses
were
employed
investigate
potential
alleviates
through
modulation
results
demonstrated
that
repaired
intestinal
barrier
dysfunction
caused
MCI,
improved
blood-brain
(BBB)
integrity,
inhibited
activation
microglial
cells
astrocytes,
significantly
ameliorated
MCI.
Furthermore,
enhanced
diversity,
notably
enriched
beneficial
bacteria
such
as
Language: Английский
Experimental Validation of Antiobesogenic and Osteoprotective Efficacy of Ginsenoside CK via Targeting Lipid and Atherosclerosis Pathways
Life,
Journal Year:
2024,
Volume and Issue:
15(1), P. 41 - 41
Published: Dec. 31, 2024
The
present
study
explored
the
possible
antiobesogenic
and
osteoprotective
properties
of
gut
metabolite
ginsenoside
CK
to
clarify
its
influence
on
lipid
atherosclerosis
pathways,
thereby
validating
previously
published
hypotheses.
These
hypotheses
were
validated
by
harvesting
cultivating
3T3-L1
MC3T3-E1
in
adipogenic
osteogenic
media
with
varying
concentrations
CK.
We
assessed
differentiation
adipocytes
osteoblasts
these
cell
lines
applying
most
effective
doses
that
we
initially
selected.
Using
vitro
assessments,
could
effectively
decrease
intracellular
accumulation,
inhibit
α-glucosidase
enzyme,
increase
2-NBDG
glucose
uptake,
reduce
inflammation-associated
cytokines
(TNFα,
IL-6),
regulatory
genes
(PPARγ,
FAS,
C/EBPα),
lipogenic
gene
LPL,
expression
thermogenic
UCP1.
Additionally,
treatment
induced
osteoblast
development
cells
as
shown
increased
mineralization
calcium
distribution,
collagen
content,
alkaline
phosphatase
activity,
decreased
inflammatory
TNFα,
IL-6
regulated
expressions
including
Runx2,
ALP,
BGLAP,
OCN,
Col1a1.
Significantly,
a
major
inhibitory
regulator,
TP53
was
down-regulated
both
MC3T3E1
after
encouraging
results
demonstrate
use
an
innovative
for
controlling
obesity
osteoporosis,
targeting
underlying
mechanisms
obesogenic
bone
loss.
Further
studies
are
necessary
explore
clinical
implications
potential
future
strategies.
This
research
highlights
promise
addressing
significant
health
issues.
Language: Английский